优化以退伍军人为中心的前列腺癌生存者照护:一项随机对照试验的研究方案
本研究为双臂随机对照试验,计划从四个退伍军人健康管理局站点招募前列腺癌生存者,每臂目标入组最多325例(预计总样本量600例)。干预组接受「建立你的新常态」个体化自动电话症状管理项目,对照组接受常规照护加非个体化症状管理通讯。主要结局为入组后5个月和12个月的症状负担、困扰及医疗服务利用变化。
要点
- 研究对象为40至80岁、治疗后1至10年且当前存在前列腺癌症状负担的退伍军人。
- 干预组接受个体化自动电话症状管理项目,对照组接受常规照护加非个体化通讯。
- 主要结局为入组后5个月和12个月的症状负担、困扰及医疗服务利用变化。
核心结论
- 中心假设是干预组参与者在干预后症状自我管理及前列腺癌生活质量将改善且更有信心,并转化为更高效的医疗服务利用。
- 研究结果将为如何优化退伍军人前列腺癌生存者的照护质量和生活质量提供急需的信息。
研究设计与样本
- 本研究为双臂随机对照试验,每臂目标入组最多325例前列腺癌生存者,预计总样本量600例。
- 患者将从四个退伍军人健康管理局站点招募。
- 患者入选标准包括年龄40至80岁、治疗后1至10年、当前存在前列腺癌症状负担。
- 干预组接受「建立你的新常态」个体化自动电话症状自我管理项目,对照组接受常规照护加非个体化症状管理通讯。
- 主要结局为入组后5个月和12个月的症状负担、困扰及医疗服务利用变化,次要结局包括长期心理社会结局(如主观健康、感知癌症控制)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although prostate cancer is the most common cancer among veterans receiving care in the Veterans Health Administration (VA), more needs to be done to understand and improve survivorship care for this large population. This study, funded by VA Health Services Research & Development (HSR&D), seeks to address the need to improve patient-centered survivorship care for veterans with prostate cancer. METHODS/DESIGN: This is a two-armed randomized controlled trial (RCT) with a target enrollment of up to 325 prostate cancer survivors per study arm (total anticipated n = 600). Patients will be recruited from four VA sites. Patient eligibility criteria include age range of 40-80 years, one to ten years post-treatment, and currently experiencing prostate cancer symptom burden. We will compare the "Building Your New Normal" program, a personally-tailored automated telephone symptom management intervention for improving symptom self-management to usual care enhanced with a non-tailored newsletter about symptom management. Primary outcomes include changes in symptom burden, bother, and health services utilization at five and 12 months after enrollment. Secondary outcomes include long-term psychosocial outcomes (e.g. subjective health, perceived cancer control). We will use multivariable regression analysis to evaluate the impact of the intervention on primary and secondary outcomes. We will conduct a process evaluation to understand the effective intervention components and explore possibilities for broader implementation and dissemination. DISCUSSION: Our central hypothesis is that intervention group participants will have improved and more confident symptom self-management and prostate cancer quality of life following the intervention and that these outcomes will translate to more efficient use of health services. The study results will provide much needed information about how to optimize the quality of care, and life, of veteran prostate cancer survivors. TRIAL REGISTRATION: ClinicalTrials.gov ID NCT01900561 ; Registered on 22 July 2013.
引用
- Skolarus TA, Metreger T, Hwang S, et al. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28420419. doi:10.1186/s13063-017-1925-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。